[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
FWD: Query from OccMed list
Forwarded message:
> From sdesilva@aeha1.apgea.army.mil Thu Sep 5 13:50:55 1996
> Message-Id: <9609051943.AA04973@aehafs1.apgea.army.mil>
> Date: Thu, 05 Sep 96 15:59:07 -0700
> From: "Shirin R. de Silva, MD, MPH" <sdesilva@aeha1.apgea.army.mil>
> Organization: USA-CHPPM
> X-Mailer: Mozilla 1.1N (Windows; I; 16bit)
> Mime-Version: 1.0
> To: occ-env-med-l@list.mc.duke.edu
> Subject: OEM: file:///c:/internet/netscape/home.htm
> Content-Transfer-Encoding: 7bit
> Content-Type: text/plain; charset=us-ascii
> Sender: owner-occ-env-med-l@list.mc.duke.edu
> Precedence: bulk
> Content-Length: 4577
>
> This is a second post to your letter. In my first post, I assumed that
> all or almost all the exposure involved internal ingestion of Iodine-131
> and Ce-137 through poor workplace hygiene, and that there was essentially
> no internal exposure to Iridium. I now realize that is in doubt.
>
> Field radiography using Iridium-192 depends on gamma radiation, and the
> components are usually well shielded. However, if the technique was as
> sloppy as you describe, the workers may sometimes have left the iridium
> source outside the shielding tube. This can result in severe radiation
> exposure. Has your patient ever had radiation burns? How about other
> people at his workplace?
>
> Iridium-192 has an annual intake limit of 80 _microcuries_ by inhalation.
> If the patient's exposure to iridium-192 of 10-20 mcuries means internal
> exposure and is in _millicuries_, then your patient is over his annual
> limits. However, your patient shouldn't have been able to inhale or
> ingest the iridium used in field radiography. How was exposure to the
> various isotopes determined? Are we talking about internal exposure
> received by the patient, or about the theoretical radioactivity of the
> material? If we are talking theoretical radioactivity, then you need to
> look at the film badge, personal dosimetry information in order to get a
> handle on your patient's exposure.
>
> If your worker uses radioactive iridium he is a radiation worker and you
> use that standard.
>
> The reference I mentioned in my previous post also deals with inhalation
> exposure assessment, if the manufacturer is unable to give you any help.
>
> I am not familiar with Ammerisium. Are you sure about the spelling? I
> would check with a health physicist, your local Nuclear Medicine
> specialist, and the U.S. Nuclear Regulatory Commision about that one.
>
> ----------------------------------------------------------------------
>
>
>
> From: CJMARTIN@PHS.Med.UAlberta.CA
> Organization: Public Health Sciences, U Alberta
> To: occ-env-med-l@list.mc.duke.edu
> Date: Wed, 4 Sep 1996 13:16:47 MDT
> Subject: OEM: Carcinoid tumour of thymus and radioisotope exposure
> Priority: normal
> X-mailer: Pegasus Mail v3.1 (R1a)
> Precedence: bulk
>
> Here is case that we would appreciate your comments on:
>
> We have just seen a 46 year old man who was employed from
> 1969 to 1978 as an oilfield cased-hole logging engineer. Essentially
> his work involved the underground injection of various radioactive
> isotopes to obtain information on the best method to extract oil and
> natural gas reserves. He was exposed to the following agents:
>
> Iridium-192 10-20 mcuries (seldom used)
>
> Ammerisium-berylium 3-5 curies (used everytime a well was
> logged, approximately 150-
> 200 times/yr)
>
> Iodine-131 20 mcuries (In liquid form, 100
>
> Cesium-137 3 curies (used 4-5 times/year)
>
>
> He describes the workers attitude towards radioactive hazards as
> "cavalier". They used no protection whatsoever. Isotopes would
> spill on clothing, blow into their faces etc. They would store them
> in the trucks to prevent freezing. When the patient took a safety
> course on radioisotopes, he recognized the danger and quit this line
> of work!
>
> He began to experience sharp retrosternal chest pain in 1981.
> After being treated for everything you could possibly imagine, he
> eventually had an open thoracotomy in 1989 at which time the tumour
> was found and a tissue sample was taken. He has had courses of
> radiotherapy and chemotherapy, his lesion is apparently unresectable.
> There has been impingement on his SVC and a stent has been inserted.
> He is aware that the cancer is terminal but, understandably, no one
> has given him a time frame. He is being followed with CT Scans every
> 6 months.
>
> We have been asked to comment on causation.
>
> He says numerous other co-workers have had various types of
> malignancy - 2 cases of leukemia, plus bowel, prostate, bladder,
> testicle. Apparently several have had thyroid abnormalities but the
> patient is unsure exactly what these are.
>
> We are in the process of:
> - Alerting our Dept of Labour to the situation
> - Obtaining all his records
> - Searching the literature
>
> Any insight or help with this case the group could provide would
> be most welcome.
>
>
> Christopher Martin
> Resident
> Occupational Health Program
> University of Alberta
> Edmonton, Alberta
>
>
>
>